title: Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin.
authors.affiliation: Oncology Section, Division of MR Research, Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
authors.forename: K
authors.initials: K
authors.lastname: Natarajan
authors.forename: N
authors.initials: N
authors.lastname: Mori
authors.forename: D
authors.initials: D
authors.lastname: Artemov
authors.forename: E O
authors.initials: EO
authors.lastname: Aboagye
authors.forename: V P
authors.initials: VP
authors.lastname: Chacko
authors.forename: Z M
authors.initials: ZM
authors.lastname: Bhujwalla
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002461:Cell Line, Transformed; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D009682:Magnetic Resonance Spectroscopy; D009361:Neoplasm Invasiveness; D010743:Phospholipids / Q000378:metabolism*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010743:Phospholipids; D007213:Indomethacin